1. Upregulation of CDGSH iron sulfur domain 2 attenuates cerebral ischemia/reperfusion injury
- Author
-
Miao Hu, Jie Huang, Lei Chen, Xiao-Rong Sun, Zi-Meng Yao, Xu-Hui Tong, Wen-Jing Jin, Yu-Xin Zhang, and Shu-Ying Dong
- Subjects
cerebral ischemia/reperfusion injury ,cdgsh iron sulfur domain 2 ,ferroptosis ,glutathione peroxidase 4 ,heme oxygenase 1 ,ht22 ,nuclear-factor e2-related factor 2 ,oxygen-glucose deprivation/reoxygenation injury ,stroke ,transferrin receptor 1 ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
CDGSH iron sulfur domain 2 can inhibit ferroptosis, which has been associated with cerebral ischemia/reperfusion, in individuals with head and neck cancer. Therefore, CDGSH iron sulfur domain 2 may be implicated in cerebral ischemia/reperfusion injury. To validate this hypothesis in the present study, we established mouse models of occlusion of the middle cerebral artery and HT22 cell models of oxygen-glucose deprivation and reoxygenation to mimic cerebral ischemia/reperfusion injury in vivo and in vitro, respectively. We found remarkably decreased CDGSH iron sulfur domain 2 expression in the mouse brain tissue and HT22 cells. When we used adeno-associated virus and plasmid to up-regulate CDGSH iron sulfur domain 2 expression in the brain tissue and HT22 cell models separately, mouse neurological dysfunction was greatly improved; the cerebral infarct volume was reduced; the survival rate of HT22 cells was increased; HT22 cell injury was alleviated; the expression of ferroptosis-related glutathione peroxidase 4, cystine-glutamate antiporter, and glutathione was increased; the levels of malondialdehyde, iron ions, and the expression of transferrin receptor 1 were decreased; and the expression of nuclear-factor E2-related factor 2/heme oxygenase 1 was increased. Inhibition of CDGSH iron sulfur domain 2 upregulation via the nuclear-factor E2-related factor 2 inhibitor ML385 in oxygen-glucose deprived and reoxygenated HT22 cells blocked the neuroprotective effects of CDGSH iron sulfur domain 2 up-regulation and the activation of the nuclear-factor E2-related factor 2/heme oxygenase 1 pathway. Our data indicate that the up-regulation of CDGSH iron sulfur domain 2 can attenuate cerebral ischemia/reperfusion injury, thus providing theoretical support from the perspectives of cytology and experimental zoology for the use of this protein as a therapeutic target in patients with cerebral ischemia/reperfusion injury.
- Published
- 2023
- Full Text
- View/download PDF